Preferred Label : receptors, antigen, t-cell;

MeSH definition : Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (ANTIGENS, CD3). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.; Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.;

MeSH synonym : t-cell receptors; t-cell antigen receptor; t cell antigen receptor; receptors, t-cell antigen; antigen receptors, t cell; antigen receptor, t-cell; receptor, t-cell antigen; receptors, t-cell; t cell receptors; t-cell receptor; receptor, t-cell; t cell receptor; receptors, t cell antigen; t-cell antigen receptors; antigen receptors, t-cell;

MeSH annotation : GEN; prefer specifics; do not confuse their gamma-delta chains with gamma & delta chains which are subunits of CD3 antigens (index under ANTIGENS, CD3); DF: RECEPT ANTIGEN T CELL; general or unspecified; prefer specifics; do not confuse their gamma-delta chains with gamma and delta chains which are subunits of CD3 antigens (index under ANTIGENS, CD3);

Wikipedia link : https://en.wikipedia.org/wiki/T-cell receptor;

Is substance : O;

Details


Main resources

You can consult :

Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (ANTIGENS, CD3). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.
Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains.

https://www.has-sante.fr/jcms/p_3467532/fr/kymriah-tisagenlecleucel-lymphome-diffus-a-grande-cellules-b-ldgcb
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
infusions, intravenous
tisagenlecleucel
Antineoplastic Agents, Immunological
receptors, antigen, t-cell
Anti-CD19 CAR T Cells Preparation
evaluation of the transparency committee
lymphoma, large B-Cell, diffuse
tisagenlecleucel

---
https://ansm.sante.fr/tableau-marr/tisagenlecleucel
2021
false
false
false
France
French
risk management
guidelines for drug use
tisagenlecleucel
infusions, intravenous
tisagenlecleucel
child
adult
patients guideline
patient education handout
tisagenlecleucel
drug storage
drug compounding
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
Adoptive Cell Therapy Agent
medical waste disposal
receptors, antigen, t-cell
receptors, antigen, t-cell
receptors, antigen, t-cell

---
https://www.has-sante.fr/jcms/p_3262259/fr/kymriah-ldgcb-tisagenlecleucel
2021
false
false
false
France
Anti-CD19 CAR T Cells Preparation
treatment outcome
insurance, health, reimbursement
tisagenlecleucel
adult
lymphoma, large B-Cell, diffuse
recurrence
infusions, intravenous
Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
evaluation of the transparency committee
tisagenlecleucel
receptors, antigen, t-cell
receptors, antigen, t-cell

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/avis-sur-le-tisagenlecleucel-pour-le-traitement-de-la-leucemie-lymphoblastique-aigue-recidivante-ou-refractaire.html
2019
false
false
false
Canada
recurrence
acute disease
Refractory cancer
treatment outcome
insurance, health, reimbursement
tisagenlecleucel
quality of life
drug costs
costs and cost analysis
child
adolescent
survival
antigens, CD19
tisagenlecleucel
drug evaluation
tisagenlecleucel
precursor cell lymphoblastic Leukemia-Lymphoma
receptors, antigen, t-cell
receptors, antigen, t-cell

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/avis-sur-le-tisagenlecleucel-pour-le-traitement-du-lymphome-diffus-a-grandes-cellules-b-recidivant-ou-refractaire.html
2019
false
false
false
Canada
tisagenlecleucel
antigens, CD19
treatment outcome
insurance, health, reimbursement
recurrence
Refractory cancer
adult
drug costs
costs and cost analysis
quality of life
tisagenlecleucel
drug evaluation
lymphoma, large B-Cell, diffuse
tisagenlecleucel
receptors, antigen, t-cell
receptors, antigen, t-cell

---
https://www.has-sante.fr/portail/jcms/c_2891692/fr/kymriah-ldgcb
https://www.has-sante.fr/portail/jcms/c_2891692/fr/kymriah-tisagenlecleucel-car-t-anti-cd19-ldgcb
2018
false
false
false
France
tisagenlecleucel
tisagenlecleucel
adult
treatment outcome
lymphoma, large B-Cell, diffuse
infusions, intravenous
recurrence
survival analysis
guidelines for drug use
tisagenlecleucel
evaluation of the transparency committee
receptors, antigen, t-cell
receptors, antigen, t-cell

---
https://www.has-sante.fr/portail/jcms/c_2888882/fr/yescarta
https://www.has-sante.fr/portail/jcms/c_2888882/fr/yescarta-axicabtagene-ciloleucel-car-t-anti-cd19
2018
false
false
false
France
French
treatment outcome
evaluation of the transparency committee
adult
lymphoma, large B-Cell, diffuse
mediastinal neoplasms
recurrence
antigens, CD19
receptors, antigen, t-cell
immunotherapy, adoptive
immunotherapy, adoptive
survival analysis
t-lymphocytes
Primary mediastinal (thymic) large B-cell lymphoma (disorder)
t-lymphocytes
receptors, antigen, t-cell
guidelines for drug use
axicabtagene ciloleucel
axicabtagene ciloleucel
axicabtagene ciloleucel

---
https://www.ema.europa.eu/medicines/human/EPAR/Kymriah
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
drug approval
europe
treatment outcome
tisagenlecleucel
tisagenlecleucel
gene therapy
child
adolescent
young adult
B Acute Lymphoblastic Leukemia
precursor b-cell lymphoblastic leukemia-lymphoma
b-lymphocytes
lymphoma, large B-Cell, diffuse
adult
recurrence
infusions, intravenous
product surveillance, postmarketing
precursor b-cell lymphoblastic leukemia-lymphoma
antigens, CD19
pregnancy
breast feeding
tisagenlecleucel
drug evaluation, preclinical
genetic therapy
receptors, antigen, t-cell
receptors, antigen, t-cell

---
https://www.ema.europa.eu/medicines/human/EPAR/Yescarta
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
orphan drug production
axicabtagene ciloleucel
adult
lymphoma, large B-Cell, diffuse
Primary mediastinal (thymic) large B-cell lymphoma (disorder)
infusions, intravenous
product surveillance, postmarketing
immunotherapy
antigens, CD19
receptors, antigen, t-cell
t-lymphocytes
t-lymphocytes
aged
pregnancy
breast feeding
axicabtagene ciloleucel
axicabtagene ciloleucel

---
https://www.ansm.sante.fr/actualites/therapie-genique-acces-precoce-aux-premiers-medicaments-innovants-car-t-cells-dans-le-traitement-de-certains-cancers-hematologiques
2018
false
false
false
France
French
drug information
genetic therapy
Chimeric Antigen Receptor T-cells
receptors, antigen, t-cell
t-lymphocytes
t-lymphocytes
transplantation, homologous
immunotherapy
lymphoma, large B-Cell, diffuse
adult
child
adolescent
burkitt lymphoma
t-lymphocytes
recurrence
receptors, antigen, t-cell

---
https://www.has-sante.fr/portail/jcms/c_2891689/fr/kymriah-lal
https://www.has-sante.fr/portail/jcms/c_2891689/fr/kymriah-tisagenlecleucel-car-t-anti-cd19-lal
2018
false
false
false
France
child
young adult
adolescent
tisagenlecleucel
tisagenlecleucel
treatment outcome
recurrence
infusions, intravenous
B Acute Lymphoblastic Leukemia
precursor b-cell lymphoblastic leukemia-lymphoma
guidelines for drug use
tisagenlecleucel
evaluation of the transparency committee
receptors, antigen, t-cell
receptors, antigen, t-cell

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.